Mednet
Mednet provides the iMednet eClinical Platform, a unified SaaS suite covering EDC, RTSM, CTMS, ePRO, eConsent, eTMF, pharmacovigilance, DICOM imaging, and related modules, sold primarily to pharmaceutical, biotech, medical device, and CRO customers across 100+ countries.
- Company typePrivate
- Founded2001
- HeadquartersMinnetonka, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Mednet does
Mednet (legal name MedNet Solutions, Inc.) is a US-based eClinical technology company founded around 2001 in Minnetonka, Minnesota, that builds and sells the iMednet eClinical Platform, a unified SaaS platform combining electronic data capture (EDC), randomization and trial supply management (RTSM), clinical trial management system (CTMS), electronic consent (eConsent), electronic patient-reported outcomes (ePRO), electronic trial master file (eTMF), clinical adjudication, DICOM imaging, pharmacovigilance and safety reporting, site payments, risk-based quality management (RBQM), and decentralized trial support within a single integrated system. The platform is built on a modern React-based user interface, supports bidirectional API integrations with external labs, imaging systems, and data warehouses, and is compliant with FDA 21 CFR Part 11, HIPAA, EU GDPR, EU MDR, FDA ICH GCP, CCPA, and the EU-U.S. Data Privacy Framework, with AES-256 encryption at rest and TLS 1.2 in transit. Mednet reports that the platform has supported over 8,000 studies, 185,000+ site users, 560,000+ clinical trial participants across 100+ countries, and has been involved in over 100 FDA drug and device approvals.
Mednet sells primarily through a direct enterprise sales motion targeting pharmaceutical, biotechnology, medical device, IVD, and academic sponsors, supplemented by a CRO partner channel (including SDC and MedTrials). Pricing is quote-based and modular, marketed as 'Enterprise Power without Enterprise Pricing' with annual billing and support for unlimited users and sites within the SaaS subscription. The company maintains a headcount of 51-100 employees and has raised approximately $20.5M across funding rounds in 2014 and 2016, led by Arrowroot Capital Management. On November 18, 2025, Mednet was acquired by CRScube, South Korea's leading eClinical provider; the combined organization now serves 1,000+ clients across Asia, Europe, and North America and is positioning itself as a unified global eClinical platform with an expanding AI-driven product roadmap.
Mednet firmographics
Firmographics- Name
- Mednet
- Legal name
- MedNet Solutions, Inc.
- Website
- https://mednetsolutions.com
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Mednet provides the iMednet eClinical Platform, a unified SaaS suite covering EDC, RTSM, CTMS, ePRO, eConsent, eTMF, pharmacovigilance, DICOM imaging, and related modules, sold primarily to pharmaceutical, biotech, medical device, and CRO customers across 100+ countries.
- Ownership category
- akta.pro rank
Mednet industry classification
Industry- Product category
- eClinical Solutions
- NAICS
- Computer Systems Design Services (541512), Other Computer Related Services (541519)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
Keywords
Where Mednet is headquartered
LocationHeadquarters
- HQ city
- Minnetonka
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Mednet business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- SaaS Subscription (iMednet Platform): Mednet operates as a Software-as-a-Service (SaaS) provider offering its iMednet eClinical platform on a subscription basis. The platform uses a flexible, modular pricing model — customers can implement only the modules required for their study. The model supports unlimited users and sites as part of enterprise power pricing, and is described as 'Enterprise Power – Without Enterprise Pricing'.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Flexible modular SaaS pricing — pay for what you use |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels8 records
Mednet product offering
Product offeringCore offering
Mednet develops and sells the iMednet eClinical Platform, a unified SaaS platform that combines Electronic Data Capture (EDC), Randomization & Trial Supply Management (RTSM), Clinical Trial Management System (CTMS), eConsent, ePRO, eTMF, pharmacovigilance, adjudication, DICOM imaging, API integration, and Risk-Based Quality Management (RBQM) modules. The platform is designed to help pharmaceutical, biotechnology, medical device sponsors, and Contract Research Organizations (CROs) accelerate study startup, improve data quality, and execute clinical trials from Phase I through submission-ready results.
Product overview
Mednet offers the iMednet eClinical Platform, a unified, modular SaaS platform designed to support the complete clinical trial lifecycle. The platform combines a core EDC module with integrated add-on modules including RTSM (Randomization & Trial Supply Management), CTMS (Clinical Trial Management System), eConsent, ePRO, eTMF, Adjudication, DICOM Imaging, Site Payments, Pharmacovigilance, API Integration, RBQM, and Virtual/Decentralized Trials. This integrated architecture eliminates silos by connecting data, workflows, and stakeholders within a single environment, enabling sponsors and CROs to accelerate study startup, improve data quality, and maintain continuity across all phases of clinical development from Phase I studies through submission-ready results.
Differentiator
Problem solved
Functional benefit
Products and services
- iMednet eClinical Platform
- Electronic Data Capture (EDC)
- Randomization & Trial Supply Management (RTSM)
- Clinical Trial Management System (CTMS)
- ePRO (Electronic Patient-Reported Outcomes)
- eConsent
- eTMF (Electronic Trial Master File)
- Clinical Adjudication
- DICOM Imaging
- Site Payments
- Pharmacovigilance & Safety Reporting
- API Integration
- Risk-Based Quality Management (RBQM)
- Virtual and Decentralized Trials
Quantifiable outcome
- Phase I study builds completed in a month or less; some builds completed in as little as a few days
- +3 more outcomes
Companies that use Mednet
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles4 records
Mednet technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability5 records
Feature15 records
Mednet partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- CRScubecoreCRScube, Korea's leading eClinical solutions provider, acquired Mednet in November 2025 to expand into the North American market. The transaction combines CRScube's strong Asian market position (supporting 6,000+ trials worldwide) with Mednet's established North American presence (having supported over 100 FDA approvals). Both companies will continue serving existing clients while working to align operations and explore integration opportunities, creating a unified global eClinical platform.
- MedTrials, Inc.coreMednet and MedTrials co-presented webinars on clinical trial transformation, including 'The Pandemic Push: Driving Disruption and Transformation in Clinical Trial Management' (June 2020). MedTrials is a clinical trial management consultancy and CRO. The partnership combined Mednet's eClinical technology with MedTrials' operational expertise to drive innovation in clinical trial management.
- Statistics & Data Corporation (SDC)coreSDC is a long-standing CRO partner of Mednet. The partnership optimized clinical trials and delivered value to sponsors through collaboration, with SDC achieving over 50% labor reduction after transitioning to the iMednet platform. SDC's feedback has informed platform evolution and feature enhancements over the partnership.
Scale indicators10 records
Recent moves8 records
Expansion highlights5 records
Mednet competitors and assessment
Company assessmentDirect peers
- Advarra: Advarra offers CTMS, eRegulatory, and eSource solutions for sites, sponsors, and CROs, with a strong presence in academic and mid-market trials. A direct competitor in the CTMS and clinical operations layer, often overlapping on RFPs with Mednet.
- ArisGlobal: ArisGlobal provides life sciences R&D technology including pharmacovigilance, regulatory, and clinical trial software (with EDC and CTMS capabilities). Comparable where Mednet's pharmacovigilance and safety reporting modules overlap, particularly for mid-sized pharma sponsors.
- Bio-Optronics: Bio-Optronics provides CTMS (Clinical Conductor), EDC, and operational software for academic medical centers and mid-sized sponsors. Comparable as a similarly positioned mid-market eClinical platform targeting the same academic and CRO-adjacent segments.
- Clario: Clario (formed via the merger of Bioclinica and ERT) delivers eCOA, EDC, imaging, and respiratory/cardiac safety services for clinical trials. Direct peer in EDC, eCOA/ePRO, and imaging endpoints where Mednet's DICOM and ePRO modules overlap.
- Signant Health: Signant provides eCOA, EDC, RTSM, patient engagement, and clinical supply solutions for global trials. Comparable to Mednet as a similarly sized eClinical specialist targeting pharma and CRO customers with a unified platform approach.
- Clinical Ink: Clinical Ink offers EDC, eCOA, ePRO, and risk-based monitoring solutions focused on mid-to-large pharma and CROs. A direct competitor to Mednet in the modular eClinical platform category serving sponsors running Phase I–IV trials.
Broad incumbents
- IQVIA (Clinical Technologies): IQVIA delivers EDC, CTMS, RBQM, and clinical analytics as part of its broader CRO and technology stack. Comparable as a broad incumbent that competes both as a CRO partner channel and as a software suite across the same sponsors Mednet serves.
- Medidata (Oracle): Medidata's Rave EDC, RTSM, CTMS, ePRO, and imaging modules are the most direct full-suite competitor to iMednet, now backed by Oracle's enterprise scale. Comparable as the category leader that Mednet positions against for unified clinical trial platforms.
- Veeva Systems: Veeva is the largest pure-play life sciences cloud software vendor, offering Veeva Vault CTMS, eTMF, and a broader clinical-to-commercial suite. It competes with Mednet at the enterprise end of the eClinical market and sets the ceiling on pricing and feature expectations for regulated buyers.
Emerging players
- Castor: Castor offers a modular eClinical platform (EDC, eConsent, ePRO, decentralized trials) targeted at academic and mid-market sponsors. It competes with Mednet for the same underserved mid-market and academic segments where modular SaaS pricing matters most.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Mednet social profiles
Digital presenceMednet compliance and trust
Trust signalCompliance8 records
Mednet financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mednet leadership team
Management profileNumber of profiles
Profiles7 records
Mednet funding detail
Funding detailFunding overview
Funding rounds2 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mednet M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mednet
What does Mednet do?
Mednet develops and sells the iMednet eClinical Platform, a unified SaaS platform that combines Electronic Data Capture (EDC), Randomization & Trial Supply Management (RTSM), Clinical Trial Management System (CTMS), eConsent, ePRO, eTMF, pharmacovigilance, adjudication, DICOM imaging, API integration, and Risk-Based Quality Management (RBQM) modules. The platform is designed to help pharmaceutical, biotechnology, medical device sponsors, and Contract Research Organizations (CROs) accelerate study startup, improve data quality, and execute clinical trials from Phase I through submission-ready results.
Is Mednet a public or private company?
Mednet is a private company. It is classified as corporate owned and is currently operating.
When was Mednet founded?
Mednet was founded in 2001. It employs 51 to 100 people.
Where is Mednet based?
Mednet is headquartered in Minnetonka, United States, in the North America region.
How does Mednet make money?
One revenue line is on record: saaS Subscription (iMednet Platform).
Who are Mednet's main competitors?
Direct peers on record are Advarra, ArisGlobal, Bio-Optronics, Clario, Signant Health and Clinical Ink. Broad incumbents are IQVIA (Clinical Technologies), Medidata (Oracle) and Veeva Systems. Castor is listed as an emerging player.
Does Mednet have an API?
Yes. Mednet offers API Integration as a solution that enables connectivity with external systems including lab instruments, biomarker vendors, data warehouses, and imaging systems. The API supports data import/export workflows and integrations with external lab/biomarker vendors. The platform leverages APIs for bidirectional integration capabilities. Developer documentation is at www.mednetsolutions.com/api-integration.
What industry is Mednet in?
Mednet's product category is eClinical Solutions. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 541512 and its SIC code is 7372.